Home
Frontida BioPharm

Frontida BioPharm Market Share Analysis for June 2026

adare pharma solutions is a global technology-driven cdmo providing product development through commercial manufacturing expertise focused on oral dosage forms for the pharmaceutical industry.

Industry: N/A

Domainfrontidabiopharm.com

Year Founded2016

Employees201 - 500

Annual Revenue$50M - $75M

Frontida BioPharm

Frontida BioPharm (including company regionals)

frontidabiopharm.com

See more website traffic and engagement information

Frontida BioPharm Revenue up to June 2026 is 50M - 75M

revenue generated by Frontida BioPharm top domains

Frontida BioPharm top domains revenue over 3 years

Revenue for Frontida BioPharm top domains

frontidabiopharm.com50M - 75M

See more with Sales Intelligence

Total visits to Frontida BioPharm's top domains

Understand Frontida BioPharm market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Frontida BioPharm's top domains

Analyze Frontida BioPharm engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Frontida BioPharm's top domains

See how Frontida BioPharm keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Frontida BioPharm top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Frontida BioPharm

These are the website technologies, by industry, used by Frontida BioPharm top domains

Payment & Currencies (6)

PayPal

Advertising (4)

DoubleClick

Widget (4)

Twemoji

Audio Video Media (2)

YouTube

More Technologies

9

See all

News & Signals from Frontida BioPharm

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsLancs Industries Inc. partners with Frontidabiopharm.Lancs worked with Frontida to conceive, design, and manufacture numerous containment products that are used to protect personnel during the manufacturing and production of its oral pharmaceutical formulations.

NewsAdare Pharma Solutions acquired Frontidabiopharm on Dec 1st '21.Adare Pharma Solutions ("Adare"), a technology-driven contract development and manufacturing organization (CDMO), announced today the acquisition of Frontida BioPharm ("Frontida"), a vertically integrated CDMO focused on oral formulations.

NewsFrontidabiopharm launched Category 1 in vitro testing and evaluation services on Jan 13th '21.Some of the features include: On January 13th, 2021, Frontida launched its new Category 1 (CAT.one™) in vitro testing and evaluation services to support the development and regulatory approvals for abuse-deterrent formulations of pain management and central nervous system (CNS) targeted therapies.